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ABSTRACT 
Background: Excoriation (Skin Picking) Disorder (SPD) is a relatively common psychiatric 
condition whose neurobiological basis is unknown.  
Aims: We sought to probe the function of fronto-striatal circuitry in SPD.  
Methods: Eighteen SPD subjects and 15 matched healthy controls undertook an executive 
planning task (Tower of London) during functional Magnetic Resonance Imaging (fMRI). 
Activation during planning was compared between groups using region of interest and whole-
brain permutation cluster approaches.  
Results: For the contrast of task minus rest, SPD subjects exhibited significant functional under-
activation in a cluster encompassing bilateral dorsal striatum (maximal in right caudate), bilateral 
anterior cingulate, and right medial frontal regions. These abnormalities were, for the most part, 
outside the usual dorsal planning network typically activated by executive planning tasks. 
Conclusions: Abnormalities of neural regions involved in habit formation, action monitoring, 
and inhibition, appear to be involved in the pathophysiology of SPD. The findings have 
implications for understanding the brain basis of excessive grooming and the relationship of SPD 
with putative obsessive compulsive spectrum disorders. 
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Excoriation (skin picking) disorder (SPD), also known as pathological skin picking, 
neurotic/psychogenic excoriation and dermatillomania, is a body-focused repetitive behavior 
(BFRB) characterized by compulsive picking of skin causing tissue damage (1). Due to the 
growing body of research and recognition of SPD as a clinically significant condition over the 
past approximately ten years, SPD is included in the 5
th
 edition of the Diagnostic and Statistical 
Manual (DSM-5) under the name Excoriation (Skin Picking) Disorder as a full disorder for the 
first time.  
SPD is associated with a significant degree of psychosocial dysfunction, poor quality of 
life, and medical complications (2-3) and appears to be a fairly common disorder in the general 
population. In recent years, prevalence studies have indicated rates of SPD between 1.2% and 
5.4% in population samples (4-7).  
From a phenomenological perspective, SPD appears similar to trichotillomania and 
onychophagia (compulsive nail-biting), in that it is characterized by repetitive and excessive 
maladaptive grooming habits that are difficult for individuals to suppress (1). Indeed, these 
different types of symptoms commonly co-occur within individuals, leading to the notion that 
they be considered body focused repetitive behaviors (BFRBs), which may share a common 
pathophysiological basis (8). Another somewhat complimentary perspective is that SPD be 
considered an Obsessive Compulsive “Spectrum” Disorder or disorder of the “Impulsive-
Compulsive Spectrum” given the overlapping phenomenological and clinical characteristics of 
SPD and Obsessive Compulsive Disorder (OCD) and high rate of co-occurrence between the two 
disorders. In a study conducted in 901 patients with OCD, for example, 16.4% of the sample met 
criteria for concomitant SPD, while 4.9% met criteria for concomitant trichotillomania (9). 
Recent etiological research examining proposed genetic and environmental risk factors for the 
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development of the Obsessive Compulsive Spectrum Disorders found a high rate of overlap 
between these disorders, especially SPD and trichotillomania (10). Therefore, the relationship 
between SPD and OCD may be particularly pertinent in terms of such a conceptualization.  
Little is known regarding the neurobiological mechanisms or constructs involved in the 
etiology of SPD. Recent structural imaging of SPD indicated reduced fractal anisotropy in tracts 
distributed bilaterally, which included white matter close to the anterior cingulate cortices, 
compared to controls (11). These regions were remarkably similar to those separately found to be 
abnormal in trichotillomania (12-13). For OCD, there exists a large body of literature, 
implicating dysregulation of the striatum (involved in habit generation) coupled with a lack of 
top-down input from cortical regions (including both medial and lateral prefrontal regions) 
responsible for various cognitive processes (14). Patients with OCD often show behavioral 
impairments in executive planning (e.g., 15-17). Such deficits extend into relatives of patients 
with OCD who are clinically asymptomatic, highlighting the centrality of this cognitive function 
and its implicated neural substrates in the pathophysiology – it may well represent an 
intermediate biological ‘vulnerability marker’ for OCD (18-19). As such, planning-related 
functional magnetic resonance imaging (fMRI) tasks represent a useful means of probing fronto-
striatal integrity in OCD and related conditions, since they challenge salient distributed neural 
circuitry. Decreased responsiveness in the (mainly dorsolateral) prefrontal cortex and caudate 
nucleus was found during fMRI executive planning in people with OCD compared to controls 
(20).  
 The objective of this study was to probe the integrity of fronto-striatal circuitry in people 
with SPD compared to matched healthy controls using an fMRI executive planning paradigm. 
We hypothesized that SPD would be associated with under-activation during planning in the 
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striatum and (dorsolateral) prefrontal cortex versus controls, supporting a neurobiological 
relationship between SPD and OCD.  
 
Method 
Study Participants 
Men and women aged 18 to 54 with a primary diagnosis of SPD based on DSM-5 criteria and a 
structured clinical interview with a board certified psychiatrist with expertise in SPD and BFRBs 
were recruited by newspaper and poster advertisements. All subjects were recruited and 
underwent neuroimaging procedures at the University of Minnesota Medical Center. 
Inclusion criteria included: 1) Subjects met DSM-5 criteria for SPD for at least the past 
12 consecutive months: a) recurrent skin picking resulting in skin lesions; b) repeated attempts to 
decrease or stop skin picking; c) picking causes clinically significant distress or impairment in 
social, occupational, or other important areas of functioning; d) picking is not due to the direct 
physiological effects of a substance (e.g., [meth]amphetamine, cocaine) or a general medical 
condition (e.g., scabies); and e) skin picking is not restricted to the symptoms of another mental 
disorder (e.g., skin picking due to fixed beliefs about skin infestation in delusional disorder or 
parasitosis, preoccupation with appearance in body dysmorphic disorder); 2) a minimum score of 
>16 on the Yale Brown Obsessive Compulsive Scale modified for Neurotic Excoriation (NE-
YBOCS; 21-22); and 3) picking behavior occurred daily for at least 30 minutes consistently over 
the past 12-months.  
 Exclusion criteria in those with SPD comprised: 1) unstable medical illness or clinically 
significant abnormalities on physical examination; 2) current pregnancy or lactation; 3) lifetime 
history of bipolar disorder type I or II, dementia, or any psychotic disorder; 4) any current (past 
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12 months) DSM-5 psychiatric disorder including OCD, body dysmorphic disorder, 
trichotillomania, gambling disorder, nicotine dependence and disruptive, impulse-control, and 
conduct disorders; 5) initiation of psychotherapy or pharmacotherapy within three months prior 
to study entry and, if taking medication, no dose changes for the preceding three months; 6) 
history of head injury or neurologic disorders; and 7) any contraindications to MRI based on 
safety screening and clinical history. In addition, no subjects had a history of hypertension or 
diabetes, conditions which may interfere with brain imaging.  
 After complete description of the study to the subjects, written informed consent was 
obtained. No secondary consents were allowed for the study (i.e., parent/guardian consent was 
not allowed). A full Institutional Review Board approved the consent procedures and all study 
procedures were carried out in accordance with the ethical principles for medical research 
involving human subjects established in the 2008 Declaration of Helsinki.  
Age and gender matched healthy control subjects were recruited via word of mouth, 
poster and newspaper advertisements. All controls were free of any lifetime psychiatric disorder 
according to the Structured Clinical Interview for DSM-IV (SCID-I) (23) and DSM-5 criteria for 
SPD.  
 
Assessments 
Subject interviews and scale administration were conducted by a board-certified psychiatrist with 
expertise in the assessment and treatment of BFRBs, OCD, and disorders of impulse control.  
Psychiatric comorbidity was assessed using the SCID-I (23). The severity of SPD was assessed 
using the Yale Brown Obsessive Compulsive Scale modified for Neurotic Excoriation (NE-
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YBOCS) (21-22). All subjects underwent a safety screening for contraindication for MRI at 
study entry and at the scanning facility to ensure safety.  
 Functional imaging was completed within seven days of the intake assessment. Given the 
unfunded nature of this study, we decided to conduct one fMRI task which, based on the OCD 
and trichotillomania literature, would offer the best opportunity to examine striatal and frontal 
lobe integrity in SPD. As such, the Tower of London (ToL) task of frontal lobe integrity was 
chosen given that this paradigm had previously been found to be sensitive to brain dysfunction in 
those with pathological gambling (24-25), obsessive compulsive disorder (20), Parkinson’s 
Disease patients (26-27), and National Football League (NFL) players with executive deficits 
(28). Given significant time and funding constraints, this task was chosen based on our 
hypotheses of executive function deficits in the SPD group and this previous research. The ToL 
has been validated in other clinical contexts but never before applied to SPD (27,29). The task 
lasted for approximately ten minutes, during which planning and subtracting problems were 
shown on a computer screen (inter-trial interval jittered 5-15 sec). For each trial, subjects were 
presented with two sets of tubes, with a random assortment of three colored balls inserted in the 
tubes. Subjects were prompted with a cue screen displaying the word “plan” or “subtract” before 
each new problem was presented. For “plan” trials, subjects were instructed to mentally 
determine the minimal number of ball moves required to make the top set of tubes match the 
bottom set of tubes. Subjects indicated their response using a button-box placed in their right 
hand by pressing one of four buttons numbered 1-4; as such, trial duration was response driven 
(for further details see 27). The task ran for 10 minutes in total. For “subtract” trials, subjects 
were instructed to count the number of balls in the top row and subtract them for the number of 
balls in the lower row. Again, responses were indicated using a button box. Both tasks used only 
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problems with correct responses of 2, 3, or 4. Subjects were not provided with feedback 
regarding the correctness of their responses in order to minimize any possible influence of error 
related feedback on brain activation. Task difficulty varied via a predefined pseudo-randomized 
sequence.  
All subjects underwent a training session before scanning to ensure that they understood 
the rules of the task and were able to perform it adequately, and to minimize the risk of between-
group behavioral differences in the scanner, which can represent major confounds in interpreting 
fMRI group differences.   
All subjects were scanned at the University of Minnesota using a 3-Tesla Siemens 
(Munich, Germany) TIM Trio MRI scanner. Three-hundred and thirty T2-weighted echo-planar 
images depicting BOLD signal were acquired, with the first ten being discarded to avoid T1-
equilibrium effects. fMRI sequence data was as follows: Acquisition time 2 s (per volume); 
Type: 2D; Slices: 32; Slice gap: 25%; Slice thickness: 3 mm; Slice order: Descending 
(32,31,...,1); FOV: 192 mm x 192 mm; Matrix: 64 x 64; Resolution: 3 mm x 3mm; TR:  2000 
ms; TE: 30 ms; Flip angle: 78 deg; Bandwidth: 2232 Hz/Px; Echo spacing: 0.51 ms.  
 
Data analysis 
Potential differences between the study groups on demographic and clinical measures of interest 
were explored using independent sample t-tests or alternative non-parametric tests as indicated, 
with significance defined as p<0.05 uncorrected for these purposes. Imaging data were pre-
processed using the methods as previously reported (27). In brief, the scan data were motion-
corrected, slice time acquisition corrected, co-registered to structural scans (standard MPRAGE), 
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and normalized to the standard Montreal Neurological Institute echo-planar imaging template. 
The resulting images were smoothed with a 8mm full-width at half-maximum Gaussian kernel.  
 We first examined whether the task activated the expected fronto-striatal planning 
network by conducting a whole brain analysis using SPM (version 5) for the plan minus subtract 
contrast, collapsing across all study participants (p<0.05 FDR corrected). The general linear 
model (GLM) included the onsets and durations of the task events convolved with the canonical 
Haemodynamic Response Function (HRF). It also included movement parameters and a constant 
term. There has been some debate in the neuroimaging field regarding the choice of FDR vs. the 
alternative family wise error (FWE) correction method for multiple comparisons (for discussion 
see e.g., 30).  Our choice of FDR correction was in order to avoid the elevated risk of false 
positives if using FWE, and in order to maintain consistency of approach with prior work (e.g. 
27-28).  
In order to explore potential differences between the groups in terms of fMRI activation, we 
used the contrast of task minus rest (since this typically yields greater variance for detection of 
cross-group effects and is more easily interpretable for such analyses, as compared to the count 
minus subtract contrast). We used two complementary analysis approaches:  
 
1. Select Region of Interest (ROI) analysis. Mean activation data were extracted from the 
activation clusters and compared cross-group using the MarsBaR Regions of Interest 
toolbox (random effects) (31). Regions of interest were defined as 10mm spheres based 
on peak activation co-ordinates derived from an independent healthy volunteer dataset 
[the first 50 healthy controls participating in (28)]; note that this dataset was entirely 
independent with no participants taking part in both studies. The ROI co-ordinates were: 
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dorsolateral prefrontal cortex left (DLPFC L) -22 14 56, DLPFC R 26 26 56, posterior 
parietal cortex left (PPC L) -36 -76 38, PPC R 44 -70 34, frontoparietal cortex right (FPC 
R) 28 50 2. MarsBaR is a particularly sensitive approach when there is a strong prior 
hypothesis, because it averages values from all voxels within the region of interest. This 
eschews the need to correct for many voxelwise comparisons and thereby increases the 
sensitivity for detecting positive effects, mitigating the risk of false negatives. 
2. Whole-brain unconstrained analysis. Cross-group differences were examined using 
robust permutation modeling (Cambridge Brain Analysis Software, CamBA; random 
effects). To provide stringent control for multiple comparisons, cluster correction was 
applied such that the expected number of false positive clusters for the contrast of interest 
was less than one. Unlike parametric methods (e.g. those used in SPM), permutation 
modeling using CamBA is robust against outliers and non-normally distributed data. 
Moreover, CamBA offers a more advanced correction approach than SPM. More 
specifically, it uses cluster weights as opposed to extents and controls for multiple 
comparisons at the cluster level with permutation modeling.  
We also examined correlations between clinical severity using the NE-YBOCS and (i) 
behavioral task measures; and (ii) extracted mean ROI and cluster values from the imaging 
analyses (Pearson’s r, uncorrected p<0.05). Correlations were also conducted between age of 
symptom onset and these measures. Exploratory t-tests (uncorrected p<0.05) were used to 
explore possible moderating influence of medication status and lifetime history of other 
psychiatric disorders in the SPD individuals, with respect to disease severity, and any behavioral 
or brain activation measures that differed between groups.  
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Results 
Sample Characteristics 
18 subjects (mean age 29.9±9.7; 100% female) with SPD and 15 age-matched control subjects 
(mean age 32.9±14.7; 86.7% female) met inclusion criteria and underwent the clinical 
assessment and functional neuroimaging. SPD subjects had a mean age of onset of 11.3±4.1 
years and a mean duration of illness of 18.6±9.1 years (Table 1). A total of 9 (50%) subjects met 
DSM-5 criteria for another lifetime psychiatric condition: n=6 major depressive disorder; n=2 
major depressive disorder and other specified anxiety disorder; n=1 generalized anxiety disorder.  
Per our exclusion criterion, however, no subjects had a current psychiatric disorder. Five subjects 
were taking stable doses of psychotropic medications at the time of imaging: three were taking a 
selective serotonin reuptake inhibitor (SSRI), and two were taking a selective noradrenergic 
reuptake inhibitor (SNRI). Of the three subjects on an SSRI, one had citalopram augmented with 
aripiprazole while another had citalopram augmented with buspirone. Of the two subjects on an 
SNRI, one was augmented with bupropion and the other had augmentation with lamotrigine.  
 No significant demographic or clinical severity differences were found between subjects 
with a history of a lifetime psychiatric disorder and those without such a history (all p>0.010) 
(age: p=0.641; age of onset: p=0.507; NE-YBOCS: p=0.243), or between those taking a 
psychotropic medication versus those not taking medication (age: p=0.108; age of onset: 
p=0.510; NE-YBOCS: p=0.569).  
 
* TABLE 1 AROUND HERE PLEASE * 
 
Imaging Results 
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No individually clinically significant MRI structural abnormalities were identified. On the Tower 
of London task, SPD subjects did not differ significantly from controls in terms of response 
times [subtract trials mean (SD): patients 3.6 seconds (0.8), controls 4.9s (2.8); p=0.10; plan 
trials: patients 8.4s (3.0), controls 8.7s (2.5); p=0.73]. Similarly, SPD subjects and controls did 
not differ significantly in terms of percentage correct on the task [subtract trials: patients 82.5 
(11.0), controls 71.7 (17.7); p=0.05; plan trials: patients 74.9 (19.5), controls 70.2 (20.4); 
p=0.51].  
 As expected, the Tower of London task activated a network of brain regions during 
executive planning, including frontal, parietal and striatal brain regions based on the plan minus 
subtract contrast. In close concordance with previous studies that have used this paradigm, 
subtracting trials from planning trials rendered a dorsal subset of these regions including 
dorsolateral prefrontal cortex and posterior parietal cortex (Table 2 and Figure 1).  
 
* TABLE 2 AND FIGURE 1 AROUND HERE PLEASE * 
 
In the region of interest (MarsBaR) analysis, no significant activation differences were 
evident between the two groups within the dorsal planning network (Table 2; p>0.05 
uncorrected; Figure 2).   
 
* TABLE 2 AND FIGURE 2 AROUND HERE PLEASE * 
 
Whole brain analysis indicated that SPD was associated with significant under-activation 
during the task versus controls in a single cluster (Table 4 and Figure 3). The cluster was 
 14 
maximal in the right caudate nucleus [14, 24, -8], and included the bilateral caudate, right 
putamen, bilateral anterior cingulate cortices, bilateral olfactory lobes, and right frontal 
(superior-medial and middle-orbital) regions. In exploratory analyses, mean activation in the 
identified brain cluster did not differ significantly as a function of medication status (p=0.676) 
nor as a function of past history of psychiatric comorbidities in the SPD group (p=0.702).  
 No significant correlation was found between mean brain activation in the identified 
cluster and task behavioral measures (p=0.603); nor between NE-YBOCS total scores and task 
behavioral measures (p=0.332). Furthermore, no significant correlation was identified between 
mean brain activation in the identified cluster and NE-YBOCS total scores (p=0.211) nor age of 
symptom onset (p=0.542).  
 
* TABLE 4 AND FIGURE 3 AROUND HERE PLEASE * 
 
Since the control group contained two male participants while the patient group had none, 
supplementary analyses investigated possible gender influences over the activation in the 
identified cluster. Activation in the identified cluster was remarkably similar as a function of 
gender in controls, and the patient-control difference in activation remained highly significant 
even when the two male controls were excluded (Supplementary Online Figure 1). 
 
Discussion 
This study comprises the first functional imaging study to be conducted in SPD, a fairly common 
disorder newly formalized in the DSM-5. Using a task of executive planning, no significant 
differences were found between the SPD and control group in terms of task performance or brain 
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activation within the neural network typically activated by this cognitive  process, using a 
region-of-interest (ROI) approach (task minus rest contrast). Using unconstrained analysis across 
the whole brain (permutation cluster analysis with stringent correction for multiple comparisons, 
for the contrast of task minus rest), SPD was associated with significant under-activation in 
distributed neural circuitry including the bilateral dorsal striatum, bilateral anterior cingulate, and 
right frontal regions. These neural abnormalities appeared to be unrelated to symptom severity, 
or age of symptom onset.  
Brain imaging has been helpful in furthering our understanding of the potential 
neurobiological mechanisms involved in other, similar compulsive behaviors such as OCD (e.g., 
32). There is an ongoing search in psychiatry for models of the neurobiological circuitry 
implicated in given disorders. Greater understanding of such circuitry is likely to have 
ramifications for novel treatments and more appropriate diagnostic classification systems (33-
34). Although caution is warranted when comparing findings across studies that have used 
somewhat different methodologies, it is interesting to contrast the intact planning performance 
we observed in SPD coupled with normal activation in the dorsal planning network according to 
the ROI analysis, to previous findings of deficient executive planning and hypoactivation in this 
network in OCD patients versus controls (20). Thus, viewed together, these results militate 
against a primary planning deficit in SPD. Rather, the data suggest that SPD is associated with 
abnormal function of neural regions outside the usual ‘planning’ network: specifically, as 
indicated by the permutation cluster analysis, hypoactivation of the dorsal striatum, anterior 
cingulate cortices, and right frontal regions. These regions are anatomically close to those found 
to be structurally abnormal in previous SPD but also trichotillomania research (11-13). Thus, it 
appears that SPD is associated not only with structural but also functional brain abnormalities in 
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regions involved in habit generation, action monitoring, and top-down inhibitory control 
processes (11). In OCD, dysfunction extends from medial to lateral prefrontal networks while in 
SPD, dysfunction may be more restricted to medial sectors of this circuitry.  
These results suggest that cognitive fMRI tasks germane to other cognitive processes, 
such as motor inhibition and habit generation, may shed more light on the pathophysiology of 
SPD than executive planning tasks. In terms of the state versus trait nature of the currently 
identified neural abnormalities, we could not detect a significant correlation between activation 
and disease severity. The study may have been too small to detect such a relationship; 
alternatively, the hypoactivation could be ‘trait’ in nature: i.e. it may exist in people at risk of 
SPD even before symptoms develop. This lack of relationship between fMRI measures and 
disease severity could also theoretically be a consequence of the severity scale measure used. 
Since the NE-YBOCS (although the gold-standard for measuring symptom severity for this 
disorder) only assesses severity over the past seven days, it may not be a good reflection of more 
of a “trait” cognitive dysfunction that arguably underlies SPD. Future work could address this 
issue by utilizing an “endophenotyping” design in which patients are recruited along with 
clinically unaffected first-degree relatives.    
The demographics, clinical characteristics, and severity of our SPD sample accord well 
with the characteristics of previously reported samples of patients with SPD (3), suggesting that 
our sample and findings may be representative of the female SPD population at large. However, 
several limitations to this current study should be considered. First, the relatively small sample 
size of both SPD patients and controls limits the power to make any definitive statements about 
neural processing in SPD. Due to the limited sample size, we opted for the dual complementary 
approaches of utilizing both an ROI analysis in conjunction with FDR correction (to maximize 
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power and minimize type-II error), and a separate whole brain permutation cluster analysis (to 
evaluate potential abnormalities in an unconstrained fashion, but at potential risk of diminished 
power). The cluster identified in the permutation analysis appeared to contain some white matter, 
a finding not uncommon in fMRI studies more broadly (see 35 for discussion). This could be due 
to imprecision in the localization of fMRI signal (particularly with gap slices) in that the regions 
could nonetheless represent grey matter activation differences; alternatively they may truly 
reflect abnormal activation associated with white matter, there being evidence elsewhere of 
structural white matter abnormalities in SPD (11). White matter findings using fMRI are, 
however, controversial and potentially problematic to interpret. Second, half of our sample had a 
lifetime psychiatric history and nearly one-third was taking a stable dose of a psychotropic 
medication at the time of imaging. This study was neither designed nor powered to address 
possible influences of medications and comorbidities on brain activation. Nonetheless, 
exploratory analyses showed that these variables did not significantly impact brain activation in 
the identified cluster in the SPD group. Future studies will need to formally address this issue 
with larger sample sizes before firm conclusions are drawn about the observed abnormal 
activation patterns being entirely attributable to disease rather than potential confounds. Given 
that subjects with SPD report high rates of psychiatric comorbidity (1,3), however, we felt that 
excluding these subjects would result in a less-generalizable sample to the SPD population at-
large, as well as diminishing power for an already relatively small study for which funding is 
scarce. Finally, and as control subjects were for the most part recruited in advance of SPD 
subjects, by chance two control participants were male while no patients were male (and we had 
anticipated some males in the patient group). Analysis confirmed, however, that inclusion of 
these two male controls did not affect the imaging results, in that the patient-control difference in 
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activation in the identified cluster remained highly significant even when both male controls 
were excluded.   
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FIGURE 1. SPM whole brain analysis: Plan minus Subtract for all participants generated 
activation within the expected network 
 
Note: p<0.05, FDR corrected 
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FIGURE 2. Tower of London task: Task minus Rest collapsed across difficulty level 
 
Abbreviations: FPC=frontoparietal cortex right; PC=parietal cortex; DLPFC=dorsallateral prefrontal cortex
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FIGURE 3. CamBA analysis: Regions of significant under-activation during the planning 
task in SPD versus controls (task minus rest) 
  
 
Note: p<0.05 uncorrected voxelwise then cluster corrected at p<1 false positive cluster across the whole brain mass 
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 TABLE 1. Characteristics of Skin Picking Disorder Subjects and Healthy Control Subjects 
 
Variable
1
 
Baseline 
Test
2 
p-value
 
SPD  
(n=18) 
Controls  
(n=15) 
Age, years  29.9 (9.7) 32.9 (14.7) t=0.703 0.488 
Sex, female, n (%) 18 (100) 13 (86.7) f 0.199 
White/Caucasian, n (%) 17 (94.4) 12 (80) f 0.308 
Single, n (%) 13 (72.2) 10 (66.7) f 1.000 
Education, n (%) 
   Less than a college degree 
   College degree or higher 
 
7 (38.9) 
11 (61.1) 
 
3 (20) 
12 (80) 
 
f 
 
0.283 
Right Handedness, n (%) 15 (83.3) 13 (86.7) f 1.000 
Age of Onset, years 11.3 (4.1)    
Any Lifetime Psychiatric Comorbidity, n 
(%) meeting DSM-IV history 
9 (50)    
NE-YBOCS, Total Score  21.9 (4.6)    
1
Variables are mean (±SD) unless otherwise indicated    
 2
t-test unless otherwise indicated (f=Fisher’s Exact Test) 
Abbreviations: NE-YBOCS = Yale Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation 
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TABLE 2. Significant activation across all subjects for plan minus subtract contrast, in 
dorsolateral prefrontal cortex and posterior parietal cortex 
 
cluster cluster peak peak peak MNI co-ordinates 
equivk p(FWE-cor) T equivZ p(FDR-cor) x,y,z {mm} 
800 <0.001 7.72 6.69 <0.001   0 -60  45 
  5.31 4.92 <0.001 18 -54  21 
  4.74 4.45 0.001   3 -60  30 
175 0.002 6.62 5.92 <0.001 -36 -81  39 
  3.82 3.66 0.007 -42 -75  21 
  3.69 3.54 0.009 -21 -81  48 
192 0.001 5.3 4.91 <0.001 -24   6  57 
55 0.204 5.26 4.87 <0.001 -15 -57  21 
362 <0.001 5.02 4.68 <0.001 42 -48  27 
  4.76 4.46 0.001 48 -66  30 
  4.74 4.45 0.001 51 -54  21 
353 <0.001 4.91 4.59 <0.001 27  12  51 
  4.8 4.5 0.001 24   3  57 
  4.35 4.12 0.002 33  30  48 
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TABLE 3. ROI approach (Marsbar): Comparison of activation between SPD subjects and 
controls within the fronto-parietal network, task minus rest contrast.  
 
ROI 
Contrast 
value 
t 
statistic 
Uncorrected 
p 
        
Left DLPFC [-22 14 56] 0.04 0.32 0.375 
Right DLPFC [26 26 56] -0.009 -0.67 0.746 
Left PPC [-36 -76 38] 0.04 0.23 0.409 
Right PPC [44 -70 34] -0.03 -0.16 0.563 
Right FPC [28 50 2] 0.05 0.36 0.359 
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TABLE 4. CamBA approach, comparison of activation between SPD subjects and controls, 
task minus rest contrast 
 
Cluster 1, size 1607 voxels 
max -3.937232 at 14.00,24.00,-8.00 mm 
in Caudate_R (72) 
Space outside regions (917 voxels) 
BA 6: Frontal_Sup_Orb_R (17 voxels) 
BA21: Olfactory_L (18 voxels) 
BA22: Olfactory_R (69 voxels) 
BA24: Frontal_Sup_Medial_R (6 voxels) 
BA26: Frontal_Mid_Orb_R (39 voxels) 
BA28: Rectus_R (83 voxels) 
BA31: Cingulum_Ant_L (9 voxels) 
BA32: Cingulum_Ant_R (38 voxels) 
BA71: Caudate_L (123 voxels) 
BA72: Caudate_R (256 voxels) 
BA74: Putamen_R (32 voxels) 
